Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001346432-22-000005
Filing Date
2022-09-16
Accepted
2022-09-16 16:50:12
Documents
3
Period of Report
2022-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166336139340916.html 3  
1 FORM 3 wf-form3_166336139340916.xml 3 6361
2 RUOSLAHTI POA erpoa22a.htm EX-24 3887
3 RUOSLAHTI POA erpoa22a001.jpg GRAPHIC 157812
  Complete submission text file 0001346432-22-000005.txt   229355
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address P.O. BOX 544 BUELLTON CA 93427
Business Address
Ruoslahti Erkki (Reporting) CIK: 0001346432 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33650 | Film No.: 221248597